Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Testosterone Therapy May Help Prevent Fractures

By HospiMedica staff writers
Posted on 03 Oct 2003
A study has shown that testosterone therapy can decrease the risk of osteoporosis in hypogonadal men by significantly increasing bone mineral density, which can prevent future bone loss and may help prevent the associated risk of fractures. More...
The findings were presented at the annual meeting of the American Society for Bone and Mineral Research in Minneapolis (MN, USA).

The study involved 291 hypogonadal males with a mean age of 58 years, who were followed for 12 months to determine the effects of testosterone replacement therapy on bone mineral density. By month 12, serum testosterone levels were in the normal range and the average mineral density of the lumbar spine rose 2.75%. In addition, body composition also improved, with a 2.42% increase in lean body mass and a 2.35% decrease in fat mass. About 20% of men over 50 experience hypogonadism. In the study, the researchers used Testim testosterone gel, produced by Auxilium Pharmaceuticals (Norristown, PA, USA).

"The study results show that Testim gel can produce significant increases in bone mineral density and improvement in body composition, helping to prevent future bone loss and also decreasing the risk of bone fractures in aging males,” said Romeo Bachand, M.D., Ph.D., chief scientific officer of Auxilium.




Related Links:
Auxilium

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.